Content area
Sage Therapeutics Inc (SAGE) - Pharmaceuticals and Healthcare Product Pipeline
Summary
Sage Therapeutics Inc (Sage) is a clinical-stage biopharmaceutical company that discovers, develops and markets drugs for the treatment of central nervous system (CNS) disorders. It develops drugs based on selective allosteric modulation of CNS synaptic and extrasynaptic receptors of NMDA and GABA. Its flagship product Zulresso (brexanolone) is a proprietary intravenous (IV) formulation administered for the treatment of postpartum depression (PPD).
This report provides outline on pipeline products by Number of Pipeline Products by Therapy Area, Indication, development stage and Partnered/Out-Licensed Products.
This report is built using information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.